Deep within GSK's infrastructure lay decades of pharmaceutical research data—clinical
trials, formulation experiments, regulatory submissions—trapped in legacy systems
with proprietary formats that no modern tool could read.
Internal IT teams had attempted extraction multiple times. Each attempt failed.
The vendor who built the original system was long gone. Documentation was sparse.
The data was effectively locked away forever.
But this wasn't just historical curiosity. This data held insights that could
accelerate current research, support regulatory compliance, and power emerging
AI initiatives. The cost of losing it was incalculable.